Keyphrases
Overall Survival
100%
Circulating Tumor Cells
100%
Metastatic Breast Cancer
100%
Prognostic Factors
100%
Lymphocytopenia
100%
Circulating Tumor Cell Count
60%
Progression-free Survival
40%
Estrogen Receptor Status
40%
Bone Metastasis
40%
Independent Prognostic Factor
40%
Positron Emission Tomography-computed Tomography (PET-CT)
20%
University of Texas
20%
Multivariate Analysis
20%
Median Overall Survival
20%
Human Epidermal Growth Factor Receptor 2 (HER2)
20%
Prognostic Significance
20%
Systemic Therapy
20%
MD Anderson Cancer Center
20%
Predictive Factors
20%
Line of Therapy
20%
Lymphocyte Count
20%
Cell Measurement
20%
18F-fluorodeoxyglucose Positron Emission Tomography/computed Tomography
20%
Fluorodeoxyglucose Positron Emission Tomography/computed Tomography
20%
Fluorine-18
20%
Medicine and Dentistry
Overall Survival
100%
Circulating Tumor Cell
100%
Metastatic Breast Cancer
100%
Prognostic Factor
100%
Lymphocytopenia
100%
Cell Count
42%
Progression Free Survival
28%
Bone Metastasis
28%
Positron Emission Tomography-Computed Tomography
28%
Estrogen Receptor
28%
Systemic Therapy
14%
Retrospective Study
14%
Computer Assisted Tomography
14%
Population Research
14%
Multivariate Analysis
14%
Malignant Neoplasm
14%
Predictive Factor
14%
Gamma Urogastrone
14%
Epidermal Growth Factor Receptor 2
14%
Fluorodeoxyglucose F 18
14%
Fluorodeoxyglucose
14%
Cytometry
14%
Fluorine-18
14%
Lymphocyte
14%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
100%
Metastatic Breast Cancer
100%
Lymphocytopenia
100%
Neoplasm
100%
Bone Metastasis
28%
Progression Free Survival
28%
Estrogen Receptor
28%
Population Study
14%
Retrospective Study
14%
Malignant Neoplasm
14%
Fluorine 18
14%
Epidermal Growth Factor Receptor 2
14%
Fluorodeoxyglucose F 18
14%
Gamma Urogastrone
14%
Fluorodeoxyglucose
14%
Immunology and Microbiology
Overall Survival
100%
Circulating Tumor Cell
100%
Lymphocytopenia
100%
Cell Count
42%
Positron Emission Tomography-Computed Tomography
28%
Progression Free Survival
28%
Computer Assisted Tomography
14%
Gamma Urogastrone
14%
Population Research
14%
Estrogen Blood Level
14%
Lymphocyte Count
14%